patients with hemophilia A(English)
- a bispecific humanized monoclonal antibody (emicizumab) given subcutaneously, restores the function of missing Factor VIIIa in these patients
- ADA, PD, PK
- Hematology, Pharmacology / pharmaceutics, Therapeutic approaches
- https://doi.org…-2018-99-118492